Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Aug 28;16(1):235–245. doi: 10.1111/ajt.13426

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 The Authors. American Journal of Transplantation published by Wiley Periodicals, Inc. on behalf of American Society of Transplant Surgeons

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Pre‐ and posttransplant autoantibody prevalence and conversion. (A) Pre‐ and posttransplant prevalence of GADA, IA‐2A, and ZnT8A in 223 SPK patients according to group. (B) Prevalence of conversion from autoantibody negative to positive for GADA, IA‐2A, and ZnT8A in 223 SPK patients according to group. P values were calculated using paired Fisher's exact test. For both panels, ZnT8A data are shown for 215 patients since pretransplant ZnT8A could not be assessed in eight patients. GADA, 65‐kDa glutamic acid decarboxylase isoform autoantibody; HG‐PCR, hyperglycemia with pancreas chronic rejection; HG‐T1DR, hyperglycemia with type 1 diabetes recurrence; HG‐UND, hyperglycemia of undetermined cause; ZnT8A, ZnT8 autoantibody.